INTERNATIONAL PATENT: CENTESSA PHARMACEUTICALS (UK) LIMITED FILES APPLICATION FOR "ANTIGEN BINDING MOLECULES THAT BIND BDCA-2"

GENEVA, Aug. 11 -- CENTESSA PHARMACEUTICALS (UK) LIMITED (1 Ashley Road, 3rd FloorAltrincham, WA14 2DT) filed a patent application (PCT/IB2025/051045) for "ANTIGEN BINDING MOLECULES THAT BIND BDCA-2" on Jan 30, 2025. With publication no. WO/2025/163564, the details related to the patent application was published on Aug 07, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HOLMES, Steve (c/o Centessa Pharmaceuticals (UK) Limited1 Ashley Road, 3rd FloorAltrinchum WA14 2DT)

Abstract: The present invention relates antigen binding molecules, particularly antibodies, fragments and variants thereo...